ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$4.10 USD
+0.01 (0.24%)
Updated May 17, 2024 04:00 PM ET
After-Market: $4.12 +0.02 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, ADC Therapeutics (ADCT) reported earnings of -$0.56 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ADCT's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 27.59%.
Earnings History
Price & Consensus
Zacks News for ADCT
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
ADCT: What are Zacks experts saying now?
Zacks Private Portfolio Services